{
  "paper_metadata": {
    "pmid": "39273284",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene with detailed penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.658_659del",
      "protein_notation": "p.Val220Ilefs*4",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "Polish and Czech patients",
        "phenotype": "hereditary breast-ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 1,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 50.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "hereditary breast-ovarian cancer",
          "evidence_sentence": "Poland and the Czech Republic also show a high frequency of BRCA2 c.658_659del (p.Val220Ilefs*4) variant (6% and 3%, respectively; Supplementary Table S1; [70])."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "no disease manifestation",
          "evidence_sentence": "Poland and the Czech Republic also show a high frequency of BRCA2 c.658_659del (p.Val220Ilefs*4) variant (6% and 3%, respectively; Supplementary Table S1; [70])."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a significant risk of hereditary breast-ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "6% in Poland, 3% in Czech Republic",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is one of the more common BRCA2 mutations in Slavic populations.",
      "key_quotes": [
        "Poland and the Czech Republic also show a high frequency of BRCA2 c.658_659del (p.Val220Ilefs*4) variant."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5286T>G",
      "protein_notation": "p.Tyr1762*",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Northern Russian patients",
        "phenotype": "hereditary breast-ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "hereditary breast-ovarian cancer",
          "evidence_sentence": "BRCA2 c.5286T>G (p.Tyr1762*) is a Northern Russian founder variant accounting for half of BRCA2 pathogenic alleles in hereditary breast-ovarian cancer patients from the Arkhangelsk region."
        }
      ],
      "functional_data": {
        "summary": "The variant leads to a premature stop codon, resulting in a truncated protein.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Half of BRCA2 pathogenic alleles in Arkhangelsk region",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is significant in the Northern Russian population.",
      "key_quotes": [
        "BRCA2 c.5286T>G (p.Tyr1762*) is a Northern Russian founder variant accounting for half of BRCA2 pathogenic alleles in hereditary breast-ovarian cancer patients from the Arkhangelsk region."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}